
- New Stock Tip thread
-
For now I'm just staying the course with Arena, Vivus did not get positive feedback from the FDA panel so that leaves two companies vying for a $10 Billion market right now, the other looks to have the same issues Vivus has. 20% of the market easily valuates ARNA @ $20 per share, that is a lowball price.
-
GRNO close at .647
up again

- New Stock Tip thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules